Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1984;64:27-31
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHETKOWSKI, R. J.
Right arrow Articles by JUDD, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHETKOWSKI, R. J.
Right arrow Articles by JUDD, H. L.

Origin of Serum Progestins in Polycystic Ovarian Disease

RYSZARD J. CHETKOWSKI, MD, R. JEFFREY CHANG, MD, JOHN DeFAZIO, MD, DAVID R. MELDRUM, MD and HOWARD L. JUDD, MD

From the Department of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, California.

The glandular origin of excess circulating steroid hormones in women with polycystic ovarian disease has been difficult to establish with previously described perturbation techniques. Recently it was demonstrated that daily administration of a potent gonadotropin-releasing hormone agonist achieves complete and reversible suppression of ovarian steroid secretion. To examine the source of C-21 steroid hormones, circulating levels were measured before and after administration of the same agonist in polycystic ovarian disease subjects and normal control subjects. Serum levels of these hormones were also determined after administration of dexamethasone and adrenocorticotropic hormone (ACTH) as well as bilateral oophorectomy. Subjects with polycystic ovarian disease exhibited significant elevations of serum pregnenolone, 17OH-pregnenolone, and 17OH-progesterone by comparison with normal control subjects. The glandular origins of the excess levels of pregnenolone and 17OH-pregnenolone were more difficult to determine and appear to be different from that of 17OH-progesterone.




This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. De Geyter, M. De Geyter, P. R. Huber, E. Nieschlag, and W. Holzgreve
Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex
Hum. Reprod., April 1, 2002; 17(4): 933 - 939.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.